Guillaume Germain

972 total citations
74 papers, 659 citations indexed

About

Guillaume Germain is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Guillaume Germain has authored 74 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 20 papers in Physiology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Guillaume Germain's work include Inhalation and Respiratory Drug Delivery (20 papers), Asthma and respiratory diseases (20 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers). Guillaume Germain is often cited by papers focused on Inhalation and Respiratory Drug Delivery (20 papers), Asthma and respiratory diseases (20 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers). Guillaume Germain collaborates with scholars based in United States, Canada and United Kingdom. Guillaume Germain's co-authors include François Laliberté, Mei Sheng Duh, Jennifer W. Wu, Patrick Lefèbvre, Michael Bogart, Richard H. Stanford, Dominique Lejeune, Beth Hahn, Héctor Ortega and Dominic Pilon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Guillaume Germain

66 papers receiving 637 citations

Peers

Guillaume Germain
Ömer Tamer Doğan Türkiye
Ju Hyun Lee South Korea
Sunny Goel United States
Arvind Bakhru United States
Palma M. Shaw United States
Guilherme Yazbek Brazil
Maria Bertilsson Sweden
Sujith V. Cherian United States
Alem Mehari United States
Nathalie Roy United States
Ömer Tamer Doğan Türkiye
Guillaume Germain
Citations per year, relative to Guillaume Germain Guillaume Germain (= 1×) peers Ömer Tamer Doğan

Countries citing papers authored by Guillaume Germain

Since Specialization
Citations

This map shows the geographic impact of Guillaume Germain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Germain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Germain more than expected).

Fields of papers citing papers by Guillaume Germain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume Germain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Germain. The network helps show where Guillaume Germain may publish in the future.

Co-authorship network of co-authors of Guillaume Germain

This figure shows the co-authorship network connecting the top 25 collaborators of Guillaume Germain. A scholar is included among the top collaborators of Guillaume Germain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillaume Germain. Guillaume Germain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mannino, David M., et al.. (2024). Fluticasone Furoate/Umeclidinium/Vilanterol Initiation Following a COPD Exacerbation: Benefits of Prompt Initiation on COPD Outcomes. Advances in Therapy. 41(12). 4557–4580. 1 indexed citations
2.
3.
Cutler, Andrew J., et al.. (2024). Healthcare resource utilization and costs associated with first versus subsequent use of cariprazine for bipolar I disorder. Journal of Medical Economics. 27(1). 1472–1484. 1 indexed citations
4.
5.
Mannino, David M., Stephen Weng, Guillaume Germain, et al.. (2024). Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease. Advances in Therapy. 42(2). 1131–1146. 3 indexed citations
6.
Sarda, Sujata P., et al.. (2024). Real-World Healthcare Resource Utilization, Healthcare Costs, and Injurious Falls Among Elderly Patients with Geographic Atrophy. Clinical ophthalmology. Volume 18. 3215–3226. 1 indexed citations
7.
8.
9.
Germain, Guillaume, et al.. (2023). OVERALL SURVIVAL (OS) AMONG PATIENTS WITH ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS). Annals of Allergy Asthma & Immunology. 131(5). S63–S64.
10.
Bogart, Michael, Guillaume Germain, François Laliberté, Dominique Lejeune, & Mei Sheng Duh. (2023). Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States. International Journal of COPD. Volume 18. 1575–1586. 6 indexed citations
11.
Laliberté, François, et al.. (2022). Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States. Therapeutic Advances in Respiratory Disease. 16. 2673696325–2673696325. 9 indexed citations
12.
McIntyre, Roger S., et al.. (2022). The real-world health resource use and costs of misdiagnosing bipolar I disorder. Journal of Affective Disorders. 316. 26–33. 7 indexed citations
13.
Mannino, David M., Michael Bogart, Guillaume Germain, et al.. (2022). Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study. Respiratory Medicine. 197. 106807–106807. 36 indexed citations
14.
Moretz, Chad, Guillaume Germain, François Laliberté, et al.. (2021). Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease. Pulmonary Therapy. 7(1). 203–219. 4 indexed citations
15.
Oglesby, Alan, et al.. (2021). 853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US. Open Forum Infectious Diseases. 8(Supplement_1). S516–S517. 1 indexed citations
16.
Kalhan, Ravi, Chad Moretz, Guillaume Germain, et al.. (2021). Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities. International Journal of COPD. Volume 16. 1149–1161. 5 indexed citations
17.
Laliberté, François, Monika Raut, Guillaume Germain, et al.. (2020). Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA. Targeted Oncology. 16(1). 85–94. 2 indexed citations
18.
Bogart, Michael, et al.. (2019). Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. SHILAP Revista de lepidopterología. 8 indexed citations
19.
Berger, Jeffrey S., Eric D. Peterson, François Laliberté, et al.. (2018). Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation. Journal of Cardiac Failure. 25(6). 436–447. 11 indexed citations
20.
LaMori, Joyce, Neeta Tandon, François Laliberté, et al.. (2015). Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C. Journal of Medical Economics. 19(4). 364–373. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ömer Tamer Doğan Breakdown of academic impact, for papers by Ju Hyun Lee Breakdown of academic impact, for papers by Sunny Goel Breakdown of academic impact, for papers by Arvind Bakhru Breakdown of academic impact, for papers by Palma M. Shaw Breakdown of academic impact, for papers by Guilherme Yazbek Breakdown of academic impact, for papers by Maria Bertilsson Breakdown of academic impact, for papers by Sujith V. Cherian Breakdown of academic impact, for papers by Alem Mehari Breakdown of academic impact, for papers by Nathalie Roy
Rankless by CCL
2026